Incidence and prediction of outcome in hypoxic-ischemic encephalopathy in Japan

Pediatrics International

Volumn 56, Issue 2, 2014, Pages 215-221

  Hayakawa, Masahiro ^a   Ito, Yushi ^b   Saito, Shigeru ^f   Mitsuda, Nobuaki ^g   Hosono, Sigeharu ^c   Yoda, Hitoshi ^d   Cho, Kazutoshi ^h   Otsuki, Katsufumi ⁱ   Ibara, Satoshi ^j   Terui, Katsuo ^k   Masumoto, Kouji ^l   Murakoshi, Takeshi ^m   Nakai, Akihito ^e   Tanaka, Mamoru ⁿ   Nakamura, Tomohiko ^o  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c NIHON UNIVERSITY   (Japan)

^d TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^e NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

^f UNIVERSITY OF TOYAMA   (Japan)

^g RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^h HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

ⁱ SHOWA UNIVERSITY   (Japan)

^j Kagoshima City Hospital   (Japan)

^k SAITAMA MEDICAL UNIVERSITY   (Japan)

^l UNIVERSITY OF TSUKUBA   (Japan)

^m SEIREI HAMAMATSU GENERAL HOSPITAL   (Japan)

ⁿ ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o NAGANO CHILDREN'S HOSPITAL   (Japan)

more..

Author keywords

hypoxic ischemic encephalopathy; magnetic resonance imaging; neurodevelopmental outcome; risk factor

Indexed keywords

ADRENALIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; LACTATE DEHYDROGENASE; LACTIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; APGAR SCORE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIRTH WEIGHT; BLOOD PH; BRADYCARDIA; CREATINE KINASE BLOOD LEVEL; DECELERATION; DELIVERY; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; FEMALE; GENDER; GESTATIONAL AGE; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INCIDENCE; INFANT; INFANT MORTALITY; INFERTILITY THERAPY; INSTRUMENTAL DELIVERY; JAPAN; LABOR; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MECONIUM; NERVE CELL DIFFERENTIATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARITY; PLACENTA DISORDER; PREDICTION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RESUSCITATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SOLUTIO PLACENTAE; UMBILICAL CORD BLOOD; COMPLICATION; HYPOXIA-ISCHEMIA, BRAIN; NEWBORN;

FEMALE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INCIDENCE; INFANT, NEWBORN; JAPAN; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84898813429     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/ped.12233     Document Type: Article

References (29)

1. de Vries LS, Jongmans MJ,. Long-term outcome after neonatal hypoxic-ischaemic encephalopathy. Arch. Dis. Child. Fetal Neonatal Ed. 2010; 95: F220-224.
2. Martinez-Biarge M, Bregant T, Wusthoff CJ, et al. White matter and cortical injury in hypoxic-ischemic encephalopathy: Antecedent factors and 2-year outcome. J. Pediatr. 2012; 161: 799-807.
3. Martinez-Biarge M, Diez-Sebastian J, Rutherford MA, Cowan FM,. Outcomes after central grey matter injury in term perinatal hypoxic-ischaemic encephalopathy. Early Hum. Dev. 2010; 86: 675-682.
4. Shah PS, Perlman M,. Time courses of intrapartum asphyxia: Neonatal characteristics and outcomes. Am. J. Perinatol. 2009; 26: 39-44.
5. van Laerhoven H, de Haan TR, Offringa M, Post B, van der Lee JH,. Prognostic tests in term neonates with hypoxic-ischemic encephalopathy: A systematic review. Pediatrics 2013; 131: 88-98.
6. Polat M, Simsek A, Tansug N, et al. Prediction of neurodevelopmental outcome in term neonates with hypoxic-ischemic encephalopathy. Eur. J. Paediatr. Neurol. 2013; 17: 288-293.
7. Thoresen M, Liu X, Jary S, et al. Lactate dehydrogenase in hypothermia-treated newborn infants with hypoxic-ischaemic encephalopathy. Acta Paediatr. 2012; 101: 1038-1044.
8. Badawi N, Kurinczuk JJ, Keogh JM, et al. Antepartum risk factors for newborn encephalopathy: the Western Australian case-control study. BMJ 1998; 317: 1549-1553.
9. Badawi N, Kurinczuk JJ, Keogh JM, et al. Intrapartum risk factors for newborn encephalopathy: The Western Australian case-control study. BMJ 1998; 317: 1554-1558.
10. Hayes BC, McGarvey C, Mulvany S, et al. A case-control study of hypoxic-ischemic encephalopathy in newborn infants at >36 weeks gestation. Am. J. Obstet. Gynecol. 2013; 209: 29e1-29e19.
11. Ferriero DM,. Neonatal brain injury. N. Engl. J. Med. 2004; 351: 1985-1995.
12. Pierrat V, Haouari N, Liska A, Thomas D, Subtil D, Truffert P,. Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: Population based study. Arch. Dis. Child. Fetal Neonatal Ed. 2005; 90: F257-261.
13. White CR, Doherty DA, Henderson JJ, Kohan R, Newnham JP, Pennell CE,. Accurate prediction of hypoxic-ischaemic encephalopathy at delivery: A cohort study. J. Matern. Fetal Neonatal Med. 2012; 25: 1653-1659.
14. Yates HL, McCullough S, Harrison C, Gill AB,. Hypoxic ischaemic encephalopathy: Accuracy of the reported incidence. Arch. Dis. Child. Fetal Neonatal Ed. 2012; 97: F77-78.
15. Sato Y, Hayakawa M, Iwata O, et al. Delayed neurological signs following isolated parasagittal injury in asphyxia at term. Eur. J. Paediatr. Neurol. 2008; 12: 359-365.
16. Wiberg N, Kallen K, Herbst A, Olofsson P,. Relation between umbilical cord blood pH, base deficit, lactate, 5-minute Apgar score and development of hypoxic ischemic encephalopathy. Acta Obstet. Gynecol. Scand. 2010; 89: 1263-1269.
17. Edwards AD, Nelson KB,. Neonatal encephalopathies. Time to reconsider the cause of encephalopathies. BMJ 1998; 317: 1537-1538.
18. Nelson KB, Dambrosia JM, Ting TY, Grether JK,. Uncertain value of electronic fetal monitoring in predicting cerebral palsy. N. Engl. J. Med. 1996; 334: 613-618.
19. Moster D, Lie RT, Irgens LM, Bjerkedal T, Markestad T,. The association of Apgar score with subsequent death and cerebral palsy: A population-based study in term infants. J. Pediatr. 2001; 138: 798-803.
20. Thorngren-Jerneck K, Herbst A,. Low 5-minute Apgar score: A population-based register study of 1 million term births. Obstet. Gynecol. 2001; 98: 65-70.
21. Casey BM, McIntire DD, Leveno KJ,. The continuing value of the Apgar score for the assessment of newborn infants. N. Engl. J. Med. 2001; 344: 467-471.
22. Odd DE, Lewis G, Whitelaw A, Gunnell D,. Resuscitation at birth and cognition at 8 years of age: A cohort study. Lancet 2009; 373: 1615-1622.
23. Perlman JM, Risser R,. Severe fetal acidemia: Neonatal neurologic features and short-term outcome. Pediatr. Neurol. 1993; 9: 277-282.
24. Ma D, Hossain M, Chow A, et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann. Neurol. 2005; 58: 182-193.
25. Walter H, Selby FW,. Lactic acid dehydrogenase isoenzymes of buffy coat cells and erythrocytes from different species. Nature 1966; 212: 613-614.
26. Miller SP, Ramaswamy V, Michelson D, et al. Patterns of brain injury in term neonatal encephalopathy. J. Pediatr. 2005; 146: 453-460.
27. Pasternak JF, Gorey MT,. The syndrome of acute near-total intrauterine asphyxia in the term infant. Pediatr. Neurol. 1998; 18: 391-398.
28. Fewtrell MS, Kennedy K, Singhal A, et al. How much loss to follow-up is acceptable in long-term randomised trials and prospective studies. Arch. Dis. Child. 2008; 93: 458-461.
29. Guillen U, DeMauro S, Ma L, et al. Relationship between attrition and neurodevelopmental impairment rates in extremely preterm infants at 18 to 24 months: A systematic review. Arch. Pediatr. Adolesc. Med. 2012; 166: 178-184.